Steiner Robert D 4
4 · Acer Therapeutics Inc. · Filed Sep 21, 2017
Insider Transaction Report
Form 4
Steiner Robert D
Chief Medical Officer
Transactions
- Other
Nonqualified Stock Option (right to buy)
2017-09-19+40,000→ 40,000 totalExercise: $2.55Exp: 2026-04-05→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Received in connection with the Issuer's business combination (the "Merger") with what was then known as "Acer Therapeutics Inc." ("Private Acer") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated June 30, 2017 among the Issuer, Opexa Merger Sub, Inc. and Private Acer, in exchange for an option to acquire 40,000 shares of common stock of Private Acer.
- [F2]Option vests in eight equal quarterly installments beginning on January 1, 2016.